ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

T P Zhang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5028090562. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper

Papers 3

[Challenges and stratigies of neoadjuvant therapy for pancreatic cancer]. Co-author DOI 10.3760/cma.j.cn112137-20201225-03469 ↗
[The value of extended surgery for pancreatic cancer in the context of neoadjuvant therapy]. Co-author DOI 10.3760/cma.j.cn112139-20200422-00323 ↗
[The guideline for neoadjuvant therapy of pancreatic cancer in China (2020 edition)]. Last author DOI 10.3760/cma.j.cn112139-20200708-00549 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiangdong Qiu · 2 shared papers, 2020–2021 · strength 0.38
- Paper [Challenges and stratigies of neoadjuvant therapy for pancreatic cancer]. DOI 10.3760/cma.j.cn112137-20201225-03469 ↗
- Paper [The guideline for neoadjuvant therapy of pancreatic cancer in China (2020 edition)]. DOI 10.3760/cma.j.cn112139-20200708-00549 ↗
Wenhao Luo · 1 shared paper, 2021 · strength 0.22
- Paper [Challenges and stratigies of neoadjuvant therapy for pancreatic cancer]. DOI 10.3760/cma.j.cn112137-20201225-03469 ↗
Zhe Cao · 1 shared paper, 2020 · strength 0.19
- Paper [The value of extended surgery for pancreatic cancer in the context of neoadjuvant therapy]. DOI 10.3760/cma.j.cn112139-20200422-00323 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.